Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FGNZZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,013
Award facts
- Contract value 100% obligated
- $20,012.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $20,012.52 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by June 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Forteo is a biologic medication commonly prescribed for osteoporosis treatment, and this delivery order represents one component of AmerisourceBergen's ongoing pharmaceutical supply support to federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. Through this vehicle, the company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning itself as a critical vendor within the federal medical supply chain. The DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may involve expanded competition in future procurement cycles.
Quick answers
Who was awarded contract SPE2DB25FGNZZ?
SPE2DB25FGNZZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FGNZZ worth?
The government has obligated $20,013 on SPE2DB25FGNZZ.
Is contract SPE2DB25FGNZZ an order under another contract?
Yes. SPE2DB25FGNZZ is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGNZZ competed?
The extent of competition for SPE2DB25FGNZZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award